Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

• Status: Completed
• Trial end date: 1988-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the therapeutic effects of anti-thymocyte globulin (ATG) in patients with aplastic anemia and related bone marrow failure diseases.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Antilymphocyte Serum; Nandrolone; Nandrolone Decanoate; Nandrolone phenpropionate

Criteria

Men and women with moderate or acute, severe, aplastic anemia.